Powell
IJ, Schwartz K, Hussain M.
Removal of the financial barrier to health care: does it impact on prostrate
cancer at presentation and survival? A comparative study between black and
white men in a Veteran Affairs system.
Urology 1995;46(6):825-30.
The authors aimed to evaluate whether there is a racial difference in
stage at presentation of prostate cancer among men who use the Veteran
Affairs (VA) medical care system. Since the VA treatment system theoretically
provides equal access to treatment across economic groups, this evaluation
aimed to shed light on whether the reported racial differences in stage
of presentation of prostate cancer is due to socioeconomic status (SES)
or access differences between blacks and whites. This study used the Detroit
Cancer Surveillance System and data from a local VA medical center from
1973 to 1992.
Blacks were slightly less likely to have presented with "local stage"
cancer than white men (54% versus 57%) and were significantly more likely
to have presented with "distant stage" cancers (25% versus 19%).
The pattern was the same when year of diagnosis was divided into two ten-year
time periods. Among the 44% of the sample for whom follow-up data were
available, a
“survival analysis showed that, in patients less than 65 years,
whites had better 5-year survival (p=0.011) and in patients older than
65 years, blacks had better 5-year survival (p=0.164).” Once stage
of presentation was taken into account, survival rates did not differ
significantly for blacks and whites, but the trends were the same. The
authors offer two possible explanations for the age crossover in mortality
– (1) older black men may represent a group with slowly growing
cancer who remained alive compared with a group with rapidly growing cancer
who died younger, and (2) white men may experience malignant transformation
to clinically significant prostate cancer at a later age. The study did
not examine whether the racial difference in stage of presentation of
disease was responsible for the racial difference in survival.
The authors state that "even though screening or early testing is
controversial, it may be appropriate for African Americans as a high-risk
population." Given the persistence of racial differences in stage
of disease at presentation and mortality rates in a theoretically financially
equal-access system, the authors "propose that [the] negative attitudes
and behaviors toward the heath care system [that were suggested by a study
based on an early detection program in Detroit] are responsible for delays
in diagnosis, and are major contributors to the presentation of advanced
prostate cancer in African -American men resulting in poorer survival."
They add, "other possibilities also exist, such as genetic and environmental
factors."